A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1)
Recruiting now · Phase 3 · Has a placebo group
Conditions studied: Healthy
In brief
The purpose of this study is to demonstrate that V181 is safe and well tolerated, elicits an immune response, and reduces the frequency of virologically confirmed dengue (VCD) of any severity, due to any of the 4 dengue serotypes, regardless of dengue serostatus at baseline in children 2 to 17 years of age.
Key facts
- Study ID
- NCT07013487
- Run by
- Merck Sharp & Dohme LLC
- People needed
- 12000
- Starts
- 2025-06-11
- Expected to finish
- 2031-10-24
- Last updated by the study team
- 2026-07-10
Who can join
Age: 2 and older, up to 17. Sex: any. Healthy volunteers: accepted.
Where it is running
- Jatinegara Primary Health Center ( Site 0102) — East Jakarta, Jakarta Special Capital Region, Indonesia (enrolling)
- Cipayung Primary Health Center ( Site 0105) — East Jakarta, Jakarta Special Capital Region, Indonesia (enrolling)
- Dr Cipto Mangunkusumo Hospital-Pediatrics ( Site 0101) — Jakarta, Jakarta Special Capital Region, Indonesia (enrolling)
- Kelapa Gading Primary Health Center ( Site 0104) — North Jakarta, Jakarta Special Capital Region, Indonesia (enrolling)
- Pasar Minggu Primary Health Center ( Site 0103) — South Jakarta, Jakarta Special Capital Region, Indonesia (enrolling)
- Songklanagarind hospital-Department of Pediatrics ( Site 0061) — Hat Yai, Changwat Songkhla, Thailand (enrolling)
- Maharaj Nakorn Chiang Mai Hospital ( Site 0066) — Muang, Chiang Mai, Thailand (enrolling)
- Kien Giang Women's and Children hospital ( Site 0091) — Rach Gia, An Giang, Vietnam (enrolling)
- Cai Lay Regional General Hospital ( Site 0093) — Cai Lậy, Tien Giang, Vietnam (enrolling)
- Quang Nam Hospital for Women and Children ( Site 0094) — Da Nang, Vietnam (enrolling)
- Dong Thap General Hospital ( Site 0092) — Dong Thập, Vietnam (enrolling)
- Pasteur Institute in Ho Chi Minh city ( Site 0089) — Ho Chi Minh City, Vietnam (enrolling)
- University Malaya Medical Centre-Department of Paediatrics ( Site 0025) — Lembah Pantai, Kuala Lumpur, Malaysia (enrolling)
- Hospital Sibu ( Site 0021) — Sibu, Sarawak, Malaysia (enrolling)
- Hospital Ampang ( Site 0028) — Ampang, Selangor, Malaysia (enrolling)
- Sunway Medical Centre ( Site 0027) — Petaling Jaya, Selangor, Malaysia (enrolling)
- Hospital Tunku Azizah-Paediatric ( Site 0022) — Kuala Lumpur, Malaysia (enrolling)
- Health Index Multispecialty And Lying-In Clinic ( Site 0042) — Bacoor, Cavite, Philippines (enrolling)
- Chong Hua Hospital ( Site 0051) — Cebu City, Cebu, Philippines (enrolling)
- Norzel Medical and Diagnostic Clinic Foundation Corp ( Site 0044) — Cebu City, Central Visayas (Region VII), Philippines (enrolling)
- Philippine General Hospital ( Site 0041) — Manila, National Capital Region, Philippines (enrolling)
- University of the Philippines Manila ( Site 0047) — Metro Manila, National Capital Region, Philippines (enrolling)
- Clinical Research Investigator Group ( Site 0110) — Bayamón, Puerto Rico (enrolling)
- San Juan Bautista School of Medicine - Clinical Research Unit ( Site 0114) — Caguas, Puerto Rico (enrolling)
- Ponce Medical School Foundation Inc./CAIMED Center ( Site 0112) — Ponce, Puerto Rico (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.